(Q40586643)

21 September 2017

Interferon-inducible MyD88 protein inhibits hepatitis B virus replication (English)

1 reference

21 September 2017

1 reference

Wei Xiong

1

1 reference

21 September 2017

Xun Wang

2

1 reference

21 September 2017

Xiaoying Liu

3

1 reference

21 September 2017

Li Xiang

4

1 reference

21 September 2017

Lingjie Zheng

5

1 reference

21 September 2017

Zhenghong Yuan

6

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

21 September 2017

1 reference

21 September 2017

319

1 reference

21 September 2017

2

1 reference

21 September 2017

306-314

1 reference

Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

Toll-like receptors: critical proteins linking innate and acquired immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

To kill or be killed: viral evasion of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

NF-kappaB and the innate immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

Immunology. A Toll for DNA vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

Global control of hepatitis B virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

Viruses and interferon: a fight for supremacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

NF-kappaB regulation in the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

Antiviral activity of interferon-alpha against hepatitis B virus can be studied in non-hepatic cells and Is independent of MxA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

Nf-kappa B, chemokine gene transcription and tumour growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

Antiviral actions of interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

7 January 2021

Viruses and interferons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

Role of NF-kappaB and myc proteins in apoptosis induced by hepatitis B virus HBx protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

7 January 2021

The hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

Transcriptional and posttranscriptional control of hepatitis B virus gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

MyD88: an adapter that recruits IRAK to the IL-1 receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

Enhancement of hepatitis B virus replication by its X protein in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Interleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a posttranscriptional mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2003.11.005

1 reference

21 September 2017

1 reference